Jason Bugno
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 10%
Papers in
-
- Dendrimers and Hyperbranched Polymers 10
- Oncology 10
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Seungpyo Hong (12 shared papers)Hao-jui Hsu (5 shared papers)Hao‐Jui Hsu (2 shared papers)Liangliang Wang (8 shared papers)Hua Laura Liang (7 shared papers)Kaiting Yang (6 shared papers)Ralph R. Weichselbaum (6 shared papers)Joanna E. Burdette (2 shared papers)
- Journals
- Journal of Clinical Investigation (3 papers)Blood (2 papers)Clinical Cancer Research (2 papers)Biomacromolecules (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Jason Bugno
27 papers receiving 1.8k citations
Jason Bugno's Hit Papers
Peers
Comparison fields: 5 of 82
- Biomaterials 339
- Drug Discovery 6
- Polymers and Plastics 262
- Oncology 295
- Immunology 213
Countries citing papers authored by Jason Bugno
This map shows the geographic impact of Jason Bugno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Bugno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Bugno more than expected).
Fields of papers citing papers by Jason Bugno
This network shows the impact of papers produced by Jason Bugno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Bugno. The network helps show where Jason Bugno may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Bugno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade Hit paper breakdown → | 2021 | 262 |
| 2 | 2022 | 186 | |
| 3 | 2016 | 172 | |
| 4 | YTHDF2 inhibition potentiates radiotherapy antitumor efficacy Hit paper breakdown → | 2023 | 171 |
| 5 | 2014 | 131 | |
| 6 | 2016 | 121 | |
| 7 | 2016 | 100 | |
| 8 | 2021 | 64 | |
| 9 | 2015 | 61 | |
| 10 | 2016 | 59 | |
| 11 | 2014 | 53 | |
| 12 | 2014 | 49 | |
| 13 | 2021 | 47 | |
| 14 | 2014 | 43 | |
| 15 | 2024 | 42 | |
| 16 | 2019 | 37 | |
| 17 | 2023 | 35 | |
| 18 | Lactobacillus rhamnosus GG induces STING-dependent IL-10 in intestinal monocytes and alleviates inflammatory colitis in mice Hit paper breakdown → | 2025 | 33 |
| 19 | 2025 | 33 | |
| 20 | 2023 | 23 |
About Jason Bugno
Jason Bugno is a scholar working on Polymers and Plastics, Oncology, Immunology, Biomaterials and Hematology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Dendrimers and Hyperbranched Polymers (10 papers), Nanoparticle-Based Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), Acute Myeloid Leukemia Research (4 papers), Immune cells in cancer (3 papers), RNA Interference and Gene Delivery (2 papers) and Probiotics and Fermented Foods (2 papers). The work is most often cited by research in Biomaterials (339 citations), Drug Discovery (6 citations), Polymers and Plastics (262 citations), Oncology (295 citations) and Immunology (213 citations). Jason Bugno has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Seungpyo Hong, Hao-jui Hsu, Hao‐Jui Hsu, Liangliang Wang, Hua Laura Liang, Kaiting Yang, Ralph R. Weichselbaum, Joanna E. Burdette, Suhair Sunoqrot and Daniel D. Lantvit. Their work appears in journals such as Journal of Clinical Investigation, Blood, Clinical Cancer Research, Biomacromolecules and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.